California Life Sciences is amplifying the innovative work being done by our member companies.
Members can submit their articles, whitepapers, blogs or announcements creating content building blocks for the broader life science ecosystem.
San Diego Cell Therapy CDMO acquired by Healthcare-Focused Private Equity Firm
By California Life Sciences Member: Cellipont Bioservices
Performance Cell Manufacturing (“PCM”), a contract development and manufacturing organization (“CDMO”) with more than 15 years of experience in manufacturing cell therapies, today announced that it has been acquired by Great Point Partners (“GPP”), a Greenwich, Connecticut based private investment firm focused on the healthcare industry. As part of the transaction, the company also announced that it will operate under a new name: Cellipont Bioservices. Read more…
Dr. Aletta Schnitzler Joins TurtleTree as Chief Scientific Officer
By California Life Sciences Member: TurtleTree
Cell-based nutrition company TurtleTree welcomes Dr. Aletta Schnitzler as its new Chief Scientific Officer (CSO). With her world-class expertise in cellular bioprocessing, Dr. Schnitzler’s appointment marks a significant stride in TurtleTree’s journey towards sustainable and efficient cellular food production. Read more…
Bristol Myers Squibb Awards “Golden Tickets” to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs
By California Life Sciences Member: Bristol Myers Squibb
Bristol Myers Squibb Company announced five innovative biotech startups as winners of the company’s 2021 Golden Ticket Contests. The winners are: RADD Pharmaceuticals and Rubik Therapeutics (LabCentral, Cambridge, MA), Waypoint Bio (BioLabs@NYULangone, New York, NY) and Altay Therapeutics and VastBiome (MBC BioLabs, San Francisco Bay Area, CA). Read more…
California Life Sciences’ Center Stage
Center Stage is a video library that provides California Life Science member companies a platform to post short video presentations that showcase their pipeline, R&D activities, and future fundraising goals to an exclusive audience of collaboration partners, representing industry, academia, investment and government within California and beyond.
- It is recommended that you include a contact email and your company name on each slide, and limit videos to no longer than 10-15 minutes.
- Please be sure that your presentation is in its final version when you submit; file must be hosted on YouTube or Vimeo.
- Video submissions are subject to review and approval by CLS.
Industry Events
Providing the necessary professional and networking resources to help our members stay connected.
Welcome to California Life Sciences Newest Members
CLS Member News
;
“We are grateful for Governor Newsom’s restoration of the Net Operating Loss/R&D tax incentives and his continued investment in the CA life sciences industry. His support helps enable companies like Dexcom to continue to innovate.” Kevin Sayer, CEO, Dexcom
Together with @SenToniAtkins and @Rendon63rd, we have reached an agreement to ensure employees continue to have access to COVID-19 supplemental paid sick leave through 9/30, and to help businesses keep their doors open and our economy moving amidst Omicron.
Thank you to our legislative leaders! R&D investment by CA allows our companies to continue to lead the global response to the pandemic and beyond!
Thanks as always to @CAgovernor and @SenToniAtkins for their partnership.
I also want to thank @AsmPhilTing and @AsmCarrillo for their crucial advocacy on sick leave, and @AsmCottie and @kevinmullin for their leadership on tax credits.
We could not do this without you.
Thank you, @BMaienschein, for always being a supporter of life sciences innovation and the critical R&D we need to develop new cures! Our member companies applaud your leadership and support for smart R&D investment.
Breaking: COVID-19 sick pay in California would return under new deal between Newsom and lawmakers. https://www.latimes.com/california/story/2022-01-25/covid-19-sick-pay-in-california-would-return-under-legislation
“R&D investment is the lifeblood of innovation & developing cures. We've seen the fruit of robust R&D investment allow our life sciences companies lead the global response to the pandemic. CLS applauds California’s investment to help meet health needs around the world.” @CLS_CEO
CA is once again advancing economic recovery by extending sick leave to frontline workers w/ Covid & providing addl support for business: restoration of R&D credits & NOL provisions; tax relief for restaurants + arts venues; & funding for Small Biz Covid-19 Relief Grant Program. https://twitter.com/cagovernor/status/1486040003192840194
Join The Conversation
